Bdh succinate is a pharmaceutical intermediate consisting of two molecules of a stereochemically defined amino alcohol derivative combined with succinic acid. It is primarily used in the manufacturing process of HIV protease inhibitors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 183388-64-9
[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester
pharmaceutical intermediate
[2S,3S,5S]-2-Amino-3-hydroxy-5-tert-butyloxycarbonylamino-1,6-diphenylhexane succinate salt
pharmaceutical intermediate
4,6-diamino-2-chloropyrimidine-5-carbonitrile
pharmaceutical intermediate
2-Amino-5-cyano-3-methylpyridine
pharmaceutical intermediate
5-Bromo-2-iodopyrimidine
pharmaceutical intermediate
2-Amino-3-methyl-5-nitropyridine
pharmaceutical intermediate
1,6-diphenylhexane
research compound
(3-(6-Phenylhexyl)phenyl)boronic acid
research reagent
butanedioic acid;bis(tert-butyl N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate)
LAGICBLJBHDBSG-VVQWQMBKSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.C(CC(=O)O)C(=O)O